MAPROTILINE - REVIEW OF ITS PHARMACOLOGICAL PROPERTIES AND THERAPEUTIC EFFICACY IN MENTAL DEPRESSIVE STATES

被引：126

作者：

PINDER, RM ^{[1
]}

BROGDEN, RN ^{[1
]}

SPEIGHT, TM ^{[1
]}

AVERY, GS ^{[1
]}

机构：

[1] AUSTRALIAN DRUG INFORMAT SERV,AUCKLAND 10,NEW ZEALAND

来源：

关键词：

D O I：

10.2165/00003495-197713050-00001

中图分类号：

R9 [药学];

学科分类号：

1007 ;

摘要：

引用

页码：321 / 352

页数：32

共 109 条

[1] AMIN M, 1973, CURR THER RES CLIN E, V15, P691
[2] ANGST J, 1972, DEPRESSIVE ILLNESS D, P245
[3] ANGST J, 1973, CLASSIFICATION PREDI, P237
[4] CLINICAL COMPARATIVE EVALUATION OF MAPROTILINE - NEW ANTIDEPRESSANT DRUG - MULTICENTER STUDY
BALESTRIERI, A
BENASSI, P
CASSANO, GB
CASTROGIOVANNI, P
CATALANO, A
COLOMBI, A
CONFORTO, C
DELSOLDA.G
GIBERTI, F
LUCCHELLI, PE
MURATORIO, A
NISTRI, M
SARTESCHI, P
[J]. INTERNATIONAL PHARMACOPSYCHIATRY, 1971, 6 (04): : 236 - 248
[5] Baltzer V, 1973, Boll Chim Farm, V112, P601
[6] BARTHOLINI E, 1975, J INT MED RES, V3, P101
[7] BARTHOLINI E, 1973, KIELHOLZ MASKED DEPR, P256
[8] BENESOVA O, 1973, ACTIV NERV SUPER, V15, P107
[9] BOTTER PA, 1976, CURR MED RES OPIN, V3, P634
[10] ASSESSMENT OF POTENTIAL DRUG INTERACTIONS WITH A NEW TRICYCLIC ANTIDEPRESSANT DRUG
BRIANT, RH
GEORGE, CF
[J]. BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 1974, 1 (02) : 113 - 118